Analogs of glucagon exhibiting GIP receptor activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9868772
APP PUB NO 20150368310A1
SERIAL NO

14408813

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are glucagon analogs which exhibit potent activity at the GIP receptor, and, as such are contemplated for use in treating diabetes and obesity. In exemplary embodiments, the glucagon analog of the present disclosures exhibit an EC50 at the GIP receptor which is within the nanomolar or picomolar range.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVO NORDISK A/SDENMARK BAGSVAERD BAGSVAERD REGION HOVEDSTADEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bleicher, Konrad H Freiburg i. Br., DE 2 14
Dimarchi, Richard D Carmel, US 132 3953
Kitas, Eric A Aesch Baselland, CH 21 372
Smiley, David L Bloomington, US 42 1216

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 16, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 16, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00